Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A1 | P30531 | 6/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6957114 | 0.90 | SLC6A1 (0.44) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| SCHEMBL6963106 | 0.90 | SLC6A1 (0.44) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL6958333 | 0.89 | LMNA (0.45) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL6957875 | 0.89 | LMNA (0.45) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| SCHEMBL6968455 | 0.88 | SIGMAR1 (0.53) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| SCHEMBL7604550 | 0.88 | SLC6A1 (0.58) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| SCHEMBL7813214 | 0.87 | ALDH1A1 (0.52) | ALDH1A1LMNACYP2D6 | |
| Hydrochloric Acid SCHEMBL6971970 | 0.87 | LMNA (0.52) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| Hydrochloric Acid SCHEMBL8194890 | 0.87 | ALDH1A1 (0.59) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 | |
| SCHEMBL6696529 | 0.87 | SLC6A1 (0.60) | SLC6A1ALDH1A1LMNACYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0869954-B1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF NEUROGENIC INFLAMMATION | NOVO NORDISK AS (DK) | 2001-09-19 | — | — | EP | claimed |
| EP-0869954-B1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF NEUROGENIC INFLAMMATION | NOVO NORDISK AS (DK) | 2001-09-19 | — | — | EP | disclosed |